The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -65.81%. However, over the past six months, we’ve seen a stronger performance of -59.90%. The price of NLSP leaped by -31.46% over the last 30 days. And in the last five days, it has fallen by -10.91%.
The stock price for NLS Pharmaceutics Ltd (NLSP) currently stands at $0.44. The stock experienced a substantial increase in the last session, hitting $0.50 after starting at $0.39. The stock’s lowest price was $0.371 before closing at $0.35.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The market performance of NLS Pharmaceutics Ltd’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.88 on 01/13/23, while the lowest value for the same duration was $0.26 on 11/16/23.
52-week price history of NLSP Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. NLS Pharmaceutics Ltd’s current trading price is -76.54% away from its 52-week high, while its distance from the 52-week low is 69.65%. The stock’s price range during this period has varied between$0.26 and $1.88. The NLS Pharmaceutics Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 0.5 million for the day, a figure considerably higher than their average daily volume of 0.14 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
NLS Pharmaceutics Ltd (NLSP) has experienced a quarterly decline of -54.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.30M and boasts a workforce of 2 employees.
NLS Pharmaceutics Ltd: Analysts’ Ratings Unveiled
As of right now, 1 analyst is rating NLS Pharmaceutics Ltd as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8137, with a change in price of -0.4789. Similarly, NLS Pharmaceutics Ltd recorded 175,442 in trading volume during the last 100 days, posting a change of -52.05%.
NLSP’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NLSP stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
NLSP Stock Stochastic Average
As of today, NLS Pharmaceutics Ltd’s raw stochastic average for the last 50 days stands at 23.99%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 37.55%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 22.78% and 18.69%, respectively.
